Literature DB >> 33494818

Management of pediatric post-infectious neurological syndromes.

Elena Bozzola1, Giulia Spina2, Massimiliano Valeriani3, Laura Papetti3, Fabiana Ursitti3, Rino Agostiniani2, Cristina Mascolo2, Margherita Ruggiero4, Chiara Di Camillo2, Anna Quondamcarlo2, Luigi Matera5, Davide Vecchio2, Luigi Memo2, Alberto Villani2.   

Abstract

BACKGROUND: Post-Infectious Neurological Syndromes (PINS) are heterogeneous neurological disorders with post or para-infectious onset. PINS diagnosis is complex, mainly related to the absence of any recognized guidelines and a univocal definition. AIM OF THE STUDY: To elaborate a diagnostic guide for PINS.
MATERIALS AND METHODS: We retrospectively analysed patients younger than 14 years old admitted to Bambino Gesù Children's Hospital in Rome for PINS from December 2005 to March 2018. Scientific literature using PubMed as research platform was analysed: the key words "Post-Infectious Neurological Syndromes" were used.
RESULTS: A polysymptomatic presentation occurred in a percentage of 88% of the children. Motor signs and visual disturbances the most observed symptoms/signs were the most detached, followed by fever, speech disturbances, sleepiness, headache and bradipsychism. Blood investigations are compatible with inflammation, as a prodromal illnesses was documented in most cases. Normal cerebral spinal fluid (CSF) characteristics has been found in the majority of the study population. Magnetic resonance imaging (MRI) was positive for demyelinating lesions. Antibiotics, acyclovir and steroids have been given as treatment. DISCUSSION: We suggest diagnostic criteria for diagnosis of PINS, considering the following parameters: neurological symptoms, timing of disease onset, blood and CSF laboratory tests, MRI imaging.
CONCLUSIONS: We propose criteria to guide clinician to diagnose PINS as definitive, probable or possible. Further studies are required to validate diagnostic criteria.

Entities:  

Keywords:  Acute demyelinating syndromes; Children; Post-infectious neurological syndromes

Year:  2021        PMID: 33494818      PMCID: PMC7836589          DOI: 10.1186/s13052-021-00968-y

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN: 1720-8424            Impact factor:   2.638


  70 in total

Review 1.  Acute disseminated encephalomyelitis: current understanding and controversies.

Authors:  Nathan P Young; Brian G Weinshenker; Claudia F Lucchinetti
Journal:  Semin Neurol       Date:  2008-02       Impact factor: 3.420

2.  Combined central and peripheral demyelination: comparison of adult and pediatric series.

Authors:  Sabrina Ravaglia; Eleonora Tavazzi; Arrigo Moglia; Mauro Ceroni; Enrico Marchioni
Journal:  Pediatr Neurol       Date:  2009-07       Impact factor: 3.372

3.  Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Authors:  Yael Hacohen; Yu Yi Wong; Christian Lechner; Maciej Jurynczyk; Sukhvir Wright; Bahadir Konuskan; Judith Kalser; Anne Lise Poulat; Helene Maurey; Esther Ganelin-Cohen; Evangeline Wassmer; Chery Hemingway; Rob Forsyth; Eva Maria Hennes; M Isabel Leite; Olga Ciccarelli; Banu Anlar; Rogier Hintzen; Romain Marignier; Jacqueline Palace; Matthias Baumann; Kevin Rostásy; Rinze Neuteboom; Kumaran Deiva; Ming Lim
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

4.  Pediatric Epstein-Barr virus-associated encephalitis: 10-year review.

Authors:  Asif Doja; Ari Bitnun; Elizabeth Lee Ford Jones; Susan Richardson; Raymond Tellier; Martin Petric; Helen Heurter; Daune MacGregor
Journal:  J Child Neurol       Date:  2006-05       Impact factor: 1.987

5.  Acute disseminated encephalomyelitis in children.

Authors:  S N Krishna Murthy; Howard S Faden; Michael E Cohen; Rohit Bakshi
Journal:  Pediatrics       Date:  2002-08       Impact factor: 7.124

Review 6.  International Pediatric MS Study Group Global Members Symposium report.

Authors:  Evangeline Wassmer; Tanuja Chitnis; Daniela Pohl; Maria Pia Amato; Brenda Banwell; Angelo Ghezzi; Rogier Q Hintzen; Lauren B Krupp; Naila Makhani; Kevin Rostásy; Marc Tardieu; Silvia Tenembaum; Amy Waldman; Emmanuelle Waubant; Andrew J Kornberg
Journal:  Neurology       Date:  2016-08-30       Impact factor: 9.910

Review 7.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

8.  Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study.

Authors:  M Atzori; P A Battistella; P Perini; M Calabrese; M Fontanin; A M Laverda; A Suppiej; P Drigo; P Grossi; L Rinaldi; P Gallo
Journal:  Mult Scler       Date:  2008-11-05       Impact factor: 6.312

Review 9.  Acute Disseminated Encephalomyelitis.

Authors:  Matthew Philip Gray; Marc H Gorelick
Journal:  Pediatr Emerg Care       Date:  2016-06       Impact factor: 1.454

Review 10.  A clinical approach to diagnosis of autoimmune encephalitis.

Authors:  Francesc Graus; Maarten J Titulaer; Ramani Balu; Susanne Benseler; Christian G Bien; Tania Cellucci; Irene Cortese; Russell C Dale; Jeffrey M Gelfand; Michael Geschwind; Carol A Glaser; Jerome Honnorat; Romana Höftberger; Takahiro Iizuka; Sarosh R Irani; Eric Lancaster; Frank Leypoldt; Harald Prüss; Alexander Rae-Grant; Markus Reindl; Myrna R Rosenfeld; Kevin Rostásy; Albert Saiz; Arun Venkatesan; Angela Vincent; Klaus-Peter Wandinger; Patrick Waters; Josep Dalmau
Journal:  Lancet Neurol       Date:  2016-02-20       Impact factor: 44.182

View more
  1 in total

Review 1.  Viruses, parkinsonism and Parkinson's disease: the past, present and future.

Authors:  Valentina Leta; Daniele Urso; Lucia Batzu; Yue Hui Lau; Donna Mathew; Iro Boura; Vanessa Raeder; Cristian Falup-Pecurariu; Daniel van Wamelen; K Ray Chaudhuri
Journal:  J Neural Transm (Vienna)       Date:  2022-08-29       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.